Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome

Romy Franken1,2, Gisela Teixido-Tura1, Maria Brion3

  • 1Servei de Cardiologia, Unitat de Marfan, Hospital Universitari, Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Abstract

Insights

Patients with haploinsufficiency (HI) FBN1 mutations in Marfan syndrome experience more severe aortic dilation and a higher risk of dissection or death compared to those with dominant negative (DN) FBN1 mutations.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Marfan Syndrome Research

Background:

  • The impact of FBN1 mutation type on cardiovascular manifestations in Marfan syndrome (MFS) remains debated.
  • FBN1 mutations are classified as dominant negative (DN) or haploinsufficiency (HI).

Purpose of the Study:

  • To investigate the influence of FBN1 mutation type (DN vs. HI) on aortic dimensions and dilation rates.
  • To assess the effect of FBN1 mutation type on cardiovascular events, including aortic dissection and mortality in MFS patients.

Main Methods:

  • Compared aortic diameters and dilation rates in MFS patients with HI-FBN1 versus DN-FBN1 mutations.
  • Utilized echocardiography to measure aortic dimensions and tracked clinical endpoints like dissection and death.
  • Classified FBN1 mutations based on their effect on fibrillin-1 protein in the extracellular matrix.

Main Results:

  • Patients with HI-FBN1 mutations exhibited larger baseline aortic root diameters compared to DN-FBN1 patients.
  • A significantly faster rate of aortic root and ascending aorta dilation was observed in the HI-FBN1 group.
  • The HI-FBN1 group showed a trend towards increased risk for combined aortic dissection and death events.

Conclusions:

  • Haploinsufficiency (HI) FBN1 mutations are associated with a more severe aortic phenotype in Marfan syndrome.
  • HI mutations lead to larger aortic diameters and accelerated dilation, increasing the risk of dissection and mortality compared to dominant negative (DN) mutations.

Related Concept Videos

Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
954
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
3.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K